85-1792-86　［取扱停止］Fumitremorgin C (5aS,12S,14aS)-1,2,3,5a,6,11,12,14a­-Octahydro-9-methoxy-12-(2-methyl-1-propen-1-yl)-5­H,14H-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-­b]indole-5,14-dione) 250ug　145674

特徴

• Inhibitor of BCRP-mediated multidrug resistance. Chemosensitizing agent; selectively reverses BCRP-mediated multidrug resistance to mitoxantrone, doxorubicin and topotecan in transfected MCF-7 cells. Does not reverse resistance in P-gp- or MRP-positive cells.
• Sequence:C22H25N3O3
• Solubility:DMSO (~10mM)
• Molecular Weight:~379.45
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：250ug
• Grade：Highly Purified
• Purity：~98% (HPLC)
• Form：Supplied as an off-white lyophilized solid.
• Molecular Formula：C22H25N3O3
• Molecular Weight Non Ab：379.45
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]